Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome

被引:15
|
作者
Guedikian, Annie A. [1 ]
Lee, Alexandria Y. [1 ]
Grogan, Tristan R. [2 ]
Abbott, David H. [3 ]
Largaespada, Karla [1 ]
Chazenbalk, Gregorio D. [1 ]
Dumesic, Daniel A. [1 ]
机构
[1] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Dept Med Stat Core, Los Angeles, CA USA
[3] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, OB GYN, Madison, WI USA
基金
美国国家卫生研究院;
关键词
Antimullerian hormone; PCOS; hyperandrogenism; estradiol; adiposity; ANTI-MULLERIAN HORMONE; FOLLICLE-STIMULATING-HORMONE; GROWTH-FACTOR-I; LUTEINIZING-HORMONE; ESTRADIOL PRODUCTION; PREMENOPAUSAL WOMEN; GENE-EXPRESSION; PRIMATE OVARY; INSULIN; SENSITIVITY;
D O I
10.1016/j.fertnstert.2017.11.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the degree to which E-2 hyperresponsiveness to FSH and antimullerian hormone (AMH) overproduction in normal-weight women with polycystic ovary syndrome (PCOS) correlate with increased antral follicle number (AFN), hyperandrogenism, and/or metabolic dysfunction. Design: Prospective cohort study. Setting: Academic medical center. Patient(s): Seven normal-weight women with PCOS (1990 National Institutes of Health criteria) ages 20-34 years and 13 age-and body mass index-(BMI-; 18.5-25 kg/m(2)) matched normoandrogenic ovulatory women were studied. Intervention(s): All women underwent basal serum hormone and metabolic measurements, FSH stimulation testing with transvaginal ovarian sonography, frequently sampled IV glucose tolerance testing, and whole-body dual-energy x-ray absorptiometry. Main Outcome Measure(s): Serum hormone/metabolite levels, 24-hour serum E-2 response to 150 IU recombinant human (rh) FSH infusion, AFN, insulin sensitivity, and body mass measurements. Result(s): Serum E-2 responsiveness to rhFSH and AMH levels were greater in women with PCOS than in BMI-and age-matched control women, as were serum androgen levels, AFN, and abdominal fat mass. In all women combined, serum E-2 responsiveness to rhFSH was associated with AFN. Serum AMH levels, however, positively correlated with AFN but remained positively correlated with serum LH and free T levels and negatively correlated with total body fat and percent body fat, adjusting for AFN. Conclusion(s): In normal-weight women with PCOS, serum E-2 hyperresponsiveness to rhFSH represents increased AFN, while elevated serum AMH levels reflect opposing effects of stimulatory reproductive (hyperandrogenism and increased AFN) versus inhibitory metabolic (body fat) factors. Given the small number of subjects reported, additional follow-up studies are required to confirm these data. (C) 2017 by American Society for Reproductive Medicine.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [2] Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance
    Ketel, Iris J. G.
    Stehouwer, Coen D. A.
    Serne, Erik H.
    Korsen, Ted J. M.
    Hompes, Peter G. A.
    Smulders, Yvo M.
    de Jongh, Renate T.
    Homburg, Roy
    Lambalk, Cornelis B.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09): : 3365 - 3372
  • [3] Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
    Dumesic, Daniel A.
    Phan, Julia D.
    Leung, Karen L.
    Grogan, Tristan R.
    Ding, Xiangmiang
    Li, Xinmin
    Hoyos, Luis R.
    Abbott, David H.
    Chazenbalk, Gregorio D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06): : 2171 - 2183
  • [4] SUBCUTANEOUS ABDOMINAL STEM CELL ADIPOGENESIS PREDICTS METABOLIC IMPROVEMENTS IN NORMAL-WEIGHT POLYCYSTIC OVARY SYNDROME WOMEN.
    Dumesic, Daniel A.
    Tulberg, Ayli
    Leung, Karen L.
    Fisch, Sam C.
    Grogan, Tristan R.
    Abbott, David H.
    Naik, Rajanigandha
    Chazenbalk, Gregorio D.
    FERTILITY AND STERILITY, 2020, 114 (03) : E42 - E42
  • [5] Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
    Dumesic, Daniel A.
    Tulberg, Ayli
    McNamara, Megan
    Grogan, Tristan R.
    Abbott, David H.
    Naik, Rajanigandha
    Lu, Gwyneth
    Chazenbalk, Gregorio D.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (11)
  • [6] Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity
    Marcondes, Jose A. M.
    Yamashita, Sylvia A. Y.
    Maciel, Gustavo A. R.
    Baracat, Edmund C.
    Halpern, Alfredo
    GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (05) : 273 - 278
  • [7] Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
    Panico, Annalisa
    Messina, Giovanni
    Lupoli, Gelsy Arianna
    Lupoli, Roberta
    Cacciapuoti, Marianna
    Moscatelli, Fiorenzo
    Esposito, Teresa
    Villano, Ines
    Valenzano, Anna
    Monda, Vincenzo
    Messina, Antonietta
    Precenzano, Francesco
    Cibelli, Giuseppe
    Monda, Marcellino
    Lupoli, Giovanni
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 423 - 429
  • [8] Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome
    Fisch, Samantha C.
    Nikou, Ariella Farzan
    Wright, Elizabeth A.
    Phan, Julia D.
    Leung, Karen L.
    Grogan, Tristan R.
    Abbott, David H.
    Chazenbalk, Gregorio D.
    Dumesic, Daniel A.
    FERTILITY AND STERILITY, 2018, 110 (07) : 1367 - 1376
  • [9] Visfatin and Resistin Serum Levels in Normal-Weight and Obese Women With Polycystic Ovary Syndrome
    Farshchian, Fatemeh
    Tehrani, Fahimeh Ramezani
    Amirrasouli, Houshang
    Pour, Hooman Rahimi
    Hedayati, Mehdi
    Kazerouni, Faranak
    Soltani, Adeleh
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2014, 12 (03)
  • [10] Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome
    Palomba, Stefano
    Falbo, Angela
    Russo, Tiziana
    Manguso, Francesco
    Tolino, Achille
    Zullo, Fulvio
    De Feo, Pierpaolo
    Orio, Francesco, Jr.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08): : 3128 - 3135